PerkinElmer
check quantity

RediJect 2-DG Fluorescent Imaging Probe (Standard kit)

XenoLight RediJect 2-DeoxyGlucosone (DG) 750 is a fluorescent imaging probe for in vivo targeting of tumors that typically exhibit elevated glucose uptake rate in comparison to surrounding tissues. To achieve maximum glucose targeting and enhanced tumor uptake, the probe has been designed to contain four 2-DG molecules per dye molecule.  

You successfully added item(s) to your cart

For laboratory use only. This product is intended for animal research only and not for use in humans.

Part Number
List Price
Your Price
Quantity
760562
644.00 EUR
more
Buy Now

Please enter valid quantity

Please login to add favorites

NULL OR EMPTY CART

Detail Information

RediJect 2-DG fluorescent imaging probe Standard Kit:

  • Novel ready-to-use probe to monitor glucose uptake in vivo non-invasively
  • Dispensed to image 20 animals
  • Maximum glucose targeting and enhanced tumor uptake
  • In vivo imaging quality, validated on IVIS imaging systems

For laboratory use only. This product is intended for animal research only and not for use in humans.

Specifications

Fluorescent Agent Type Targeted
Optical Imaging Classification Fluorescence Imaging
Product Brand Name XenoLight
Quantity in a Package Amount 20.0 Units
Shipping Condition Blue Ice
Therapeutic Area Arthritis, Inflammation, Oncology/Cancer
Unit Size 1 Kit (20 animals)
Wave Length 750 nm
Resources, Events & More
  • All

Brochure

XenoLight RediJect 2-DG-750 Probe (Product Sheet)

XenoLight RediJect 2-DeoxyGlucosone (DG)-750 is a fluorescent,probe for in vivo targeting of tumors that typically exhibit elevated,glucose uptake rate in comparison to surrounding tissues. To achieve,maximum glucose targeting and enhanced tumor uptake, the probe,has been designed to contain four 2-DG molecules per dye molecule.,As indicated in Figure 1, RediJect 2-DG-750 probe showed specific,accumulation to LL-2 tumors shortly after delivery. In addition, specific,tumor labeling with the RediJect 2-DG-750 probe has also been,demonstrated with Breast (MDA-MB-231) Prostate (PC-3M) and Lung,(NCI-H460) tumors, further validating the utility of this probe as a generic fluorescence reagent for in vivo tumor targeting.

PDF 985 KB